PubMed COVID-19 Clinical Care
20641 - 20650 of 51970 results found
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases
Description
CONCLUSIONS: Our findings indicate that NMV-r to treat COVID-19 could reduce all-cause hospitalization and death in patients with CVDs.
"It was too much for me": mental load, mothers, and working from home during the COVID-19 pandemic
Description
This study analyses the experiences of working from home (WfH) during the COVID-19 pandemic and the impact it has on working mothers through the lens of "mental load." Remote study, often lauded as a way to reduce work/life conflicts, can bring new
Effects of wearing masks during COVID-19 pandemic on the composition and diversity of skin bacteria and fungi in medical workers
Description
CONCLUSION: Wearing different types of masks and changing masks according to different frequency will have different effects on the facial skin's microbiota.
Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh
Description
INTRODUCTION: Co-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials
Description
CONCLUSIONS: Two doses of this study vaccine, KCONVAC, were well tolerated and immunogenic in children 3 to 17 years of age.
Evaluation of oral small molecule drugs for the treatment of COVID-19 patients: a systematic review and network meta-analysis
Description
CONCLUSIONS: When compared to other antiviral medications, paxlovid can reduce the mortality and hospitalization of COVID-19 patients.
Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection
Description
Since its outbreak in late 2021, the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely reported to be able to evade neutralizing antibodies, becoming more transmissible while causing milder symptoms than
